Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy

HM Prince, J Bashford, D Wall, D Rischin, N Parker, GC Toner, JF Seymour, D Blakey, D Haylock, P Simmons, P Francis, M Wolf, EH Januszewicz, G Richardson, J Scarlett, P Briggs